Robert S DiPaola

Outcomes of localized prostate cancer following conservative management.

Dirk F Moore, Michael J Barry, Peter C Albertsen, 2009, JAMA.

Principles and Current Strategies for Targeting Autophagy for Cancer Treatment

William A Weiss, Jennifer Lippincott-Schwartz, Eileen White, 2011, Clinical Cancer Research.

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

David F Jarrard, Yu-Ning Wong, Nicholas J Vogelzang, 2015, The New England journal of medicine.

Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in Oncology

Shridar Ganesan, Wenjin Chen, Evita Sadimin, 2017, Cancer informatics.

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

David F Jarrard, Nicholas J Vogelzang, C. Kyriakopoulos, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

Shridar Ganesan, R. DiPaola, S. Ganesan, 2016, Gynecologic oncology.

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.

Gyan Bhanot, Shridar Ganesan, Hua Zhong, 2016, The Journal of clinical investigation.

Survival following primary androgen deprivation therapy among men with localized prostate cancer.

Dirk F Moore, Peter C Albertsen, R. DiPaola, 2008, JAMA.

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

Xin Victoria Wang, Keith T Flaherty, J. Manola, 2017, Clinical Cancer Research.

Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy

David J Foran, Robin Mathew, Eileen White, 2008, The Prostate.